8-KCorporate ChangesExhibits & Filings

CVS HEALTH Corp 8-K Report, Bylaw Amendment (Feb 6, 2008)

Filed February 6, 2008For Securities:CVS

Summary

CVS Health Corporation (CVS), filed an 8-K report on February 5, 2008, detailing an amendment to its by-laws. The primary focus of this filing is the addition of a new Article VI, Section 8 to the Company's by-laws. This amendment establishes specific terms and conditions under which the Board of Directors can amend a stockholder rights plan (commonly known as a 'poison pill') or similar anti-takeover devices, particularly concerning the extension of their terms beyond one year. It is important to note for investors that at the time of this filing, CVS Caremark Corporation did not have such a stockholder rights plan or anti-takeover device in place. This amendment outlines the procedural requirements should the company decide to implement or modify such a plan in the future. The filing also includes the Amended and Restated By-laws as an exhibit.

Key Highlights

  • 1CVS Caremark Corporation (CVS) filed an 8-K on February 5, 2008, reporting an amendment to its by-laws.
  • 2A new by-law (Article VI, Section 8) has been added, governing amendments to stockholder rights plans ('poison pills').
  • 3The amendment specifies conditions for the Board to amend a poison pill, particularly if extending its term beyond one year.
  • 4The company explicitly states that it does not currently have a stockholder rights plan or similar anti-takeover device in effect.
  • 5This by-law change provides a framework for future board actions regarding anti-takeover measures.
  • 6The Amended and Restated By-laws, effective February 5, 2008, were filed as an exhibit to the 8-K.

Frequently Asked Questions

The main purpose of this 8-K filing is to report an amendment to CVS Caremark Corporation's by-laws. Specifically, a new provision was added that sets forth the terms and conditions under which the Board of Directors can amend a stockholder rights plan (poison pill) or a similar anti-takeover device, especially if its term is extended beyond one year.

No, according to the filing, CVS Caremark Corporation did not have a stockholder rights plan or any anti-takeover device with a similar effect in place at the time of this report (February 5, 2008).

The amendment provides a procedural framework and establishes conditions for the Board of Directors to follow should they decide to implement or modify a stockholder rights plan or similar anti-takeover measure in the future. This proactive step ensures that the process for adopting or extending such defenses is clearly defined.

The filing was signed by David B. Rickard, Executive Vice President, Chief Financial Officer & Chief Administrative Officer of CVS Caremark Corporation, on behalf of the company.